The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: A literature-based review

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 16, 2009, Pages 2581-2592

  Juniper, Melissa ^a   Le, Trong Kim ^b   Mladsi, Deirdre ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Chronic low back pain; Cost of illness; Epidemiology; Pharmacotherapies; Therapeutics

Indexed keywords

ACEMETACIN; ANALGESIC AGENT; ANESTHETIC AGENT; DICLOFENAC; ETORICOXIB; FENTANYL; FLURBIPROFEN; IBUPROFEN; IMMUNOGLOBULIN; INDOMETACIN; KETOPROFEN; MORPHINE; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; TIAPROFENIC ACID;

ABSENTEEISM; CHRONIC PAIN; COST BENEFIT ANALYSIS; DAILY LIFE ACTIVITY; ELECTROSTIMULATION THERAPY; FRANCE; GERMANY; HEALTH CARE COST; HUMAN; ITALY; KINESIOTHERAPY; LOW BACK PAIN; MASSAGE; MEDICAL LITERATURE; MEDICAL PRACTICE; PATIENT COUNSELING; PSYCHOTHERAPY; REVIEW; SPAIN; UNITED KINGDOM; WORKMAN COMPENSATION;

ABSENTEEISM; CHRONIC DISEASE; COST OF ILLNESS; EUROPE; GREAT BRITAIN; HUMANS; LOW BACK PAIN;

EID: 72949090125     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903304063     Document Type: Review

References (27)

1. Airaksinen O, Brox JI, Cedraschi C, et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006;15(Suppl 2):S192-3
2. Duquesnoy B. Spinal pain. Rev Prat 2006;56:1015-1020
3. Negrini S, Giovannoni S, Minozzi S, et al. Diagnostic therapeutic flow-charts for low back pain patients: The Italian clinical guidelines. Eura Medicophys 2006;42:151-170
4. van Tulder M, Becker A, Bekkering T, et al.; COST B13 Working Group on Guidelines for the Management of Acute Low Back Pain in Primary Care. Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006;15(Suppl 2):S169-91
5. Revel M, Poiraudeau S. Lumbago: Diagnostic indications. Rev Prat 1998;48:689-693
6. Campbell C, Muncer SJ. The causes of low back pain: A network analysis. Soc Sci Med 2005;60:409-419
7. Müller G. Problems of diagnostic assessment in low back patients. Schmerz 2001;15:435-441
8. Pfingsten M, Schops P. Low back pain: From symptom to chronic disease. Z Orthop Ihre Grenzgeb 2004;142:146-152
9. Jones GT, Johnson RE, Wiles NJ, et al. Predicting persistent disabling low back pain in general practice: A prospective cohort study. Br J Gen Pract 2006;56:334-341
10. World Health Organization. International classification of diseases, 10th Revision. Geneva: WHO, 2007. Available from: http://www.who.int/ classifications/apps/ icd/icd10online/
11. Oxford Centre for Evidence-based Medicine. Oxford centre for evidence-based medicine levels of evidence. May 2001. Available from: http://www.cebm.net/index.aspx?o=1025. [Last accessed September 2008]
12. Salaffi F, De Angelis R, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: Results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005;23:819-828
13. Waxman R, Tennant A, Helliwell P. A prospective follow-up study of low back pain in the community. Spine 2000;25:2085-2090
14. Leclerc A, Chastang JF, Ozguler A, et al. Chronic back problems among persons 30 to 64 years old in France. Spine 2006;31:479-484
15. Cecchi F, Debolini P, Lova RM, et al. Epidemiology of back pain in a representative cohort of Italian persons 65 years of age and older: The InCHIANTI study. Spine 2006;31:1149-1155
16. Carmona L, Ballina J, Gabriel R, Laffon A. The burden of musculoskeletal diseases in the general population of Spain: Results from a national survey. Ann Rheum Dis 2001;60:1040-1045
17. Violante FS, Fiori M, Fiorentini C, et al. Associations of psychosocial and individual factors with three different categories of back disorder among nursing staff. J Occup Health 2004;46:100-108
18. Pincus T, Newman S. Recall bias, pain, depression and cost in back pain patients. Br J Clin Psychol 2001;40:143-156
19. Gülich M, Engel EM, Rose S, et al. Development of a guideline for rehabilitation of patients with low back pain - phase 2: Analysis of data of the classification of therapeutic procedures. Rehabilitation (Stuttg) 2003;42:109-117
20. Merkesdal S, Bernitt K, Busche T, et al. Comparison of costs of illness in the year before and after inpatient and outpatient rehabilitation in persons with spinal disorders. Rehabilitation (Stuttg) 2004;43:83-89
21. González Viejo MA, Condón Huerta MJ. Disability from low back pain in Spain. Med Clin (Barc) 2000;114:491-492
22. Watson PJ, Main CJ, Waddell G, et al. Medically certified work loss, recurrence and costs of wage compensation for back pain: A follow-up study of the working population of Jersey. Br J Rheumatol 1998;37:82-86
23. German Medical Society Drug Committee. Treatment guideline - backache. Z Arztl Fortbild Qualitatssich 1997;91:457-460
24. Kalso E, Allan L, Dobrogowski J, et al. Do strong opioids have a role in the early management of back pain? Recommendations from a European expert panel. Curr Med Res Opin 2005;21:1819-1828
25. Becker A, Chenot JF, Niebling W, et al. Guidelines for back pain. Z Orthop Ihre Grenzgeb 2004;142:716-719
26. European Medicines Agency. Website. Available from: http://www.emea. europa.eu/ [Last accessed June 2007]
27. Electronic Medicines Compendium (eMC). Website. Available from: http:// medicines.org.uk/home.aspx [Last accessed June 2007]